US Stock MarketDetailed Quotes

INFI Infinity Pharmaceuticals

Watchlist
  • 0.008
  • 0.0000.00%
15min DelayTrading Oct 3 16:00 ET
726.09KMarket Cap-17P/E (TTM)

Infinity Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
-15.01%583K
12.12%731K
39.56%2.59M
20.40%543K
66.36%712K
33.98%686K
39.61%652K
8.09%1.86M
3.44%451K
-13.71%428K
Operating revenue
-15.01%583K
12.12%731K
39.56%2.59M
20.40%543K
66.36%712K
33.98%686K
39.61%652K
8.09%1.86M
3.44%451K
-13.71%428K
Cost of revenue
-14.98%352K
12.21%441K
39.55%1.56M
20.22%327K
66.28%429K
34.42%414K
39.36%393K
8.00%1.12M
3.42%272K
-13.71%258K
Gross profit
-15.07%231K
11.97%290K
39.57%1.03M
20.67%216K
66.47%283K
33.33%272K
40.00%259K
8.21%738K
3.47%179K
-13.71%170K
Operating expense
-15.78%10.35M
-6.86%11.8M
0.12%45.87M
-16.48%9.75M
2.23%11.16M
7.29%12.29M
7.64%12.67M
16.95%45.82M
12.23%11.68M
20.77%10.92M
Selling and administrative expenses
7.41%3.75M
61.70%5.94M
-5.02%13.46M
-14.47%2.79M
-8.99%3.5M
-0.09%3.5M
3.08%3.68M
14.14%14.17M
1.12%3.26M
31.30%3.85M
-General and administrative expense
7.41%3.75M
61.70%5.94M
-5.02%13.46M
-14.47%2.79M
-8.99%3.5M
-0.09%3.5M
3.08%3.68M
14.14%14.17M
1.12%3.26M
31.30%3.85M
Research and development costs
-24.99%6.6M
-34.89%5.85M
2.41%32.41M
-17.26%6.96M
8.34%7.66M
10.53%8.8M
9.62%8.99M
18.26%31.65M
17.23%8.42M
15.72%7.07M
Operating profit
15.79%-10.12M
7.25%-11.51M
0.53%-44.84M
17.06%-9.54M
-1.22%-10.88M
-6.82%-12.02M
-7.12%-12.41M
-17.11%-45.08M
-12.38%-11.5M
-21.54%-10.75M
Net non-operating interest income expense
0.00%-45K
0.00%-45K
0.00%-180K
0.00%-45K
0.00%-45K
0.00%-45K
0.00%-45K
92.64%-180K
93.00%-45K
92.81%-45K
Non-operating interest expense
0.00%45K
0.00%45K
0.00%180K
0.00%45K
0.00%45K
0.00%45K
0.00%45K
-92.64%180K
-93.00%45K
-92.81%45K
Other net income (expense)
171.43%209K
3,068.75%507K
65,400.00%655K
433.02%353K
154.88%209K
185.19%77K
900.00%16K
-99.78%1K
-138.27%-106K
230.16%82K
Gain on sale of security
171.43%209K
3,068.75%507K
65,400.00%655K
433.02%353K
154.88%209K
185.19%77K
900.00%16K
-99.78%1K
-138.27%-106K
230.16%82K
Income before tax
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Income tax
Net income
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Net income continuous Operations
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Minority interest income
Net income attributable to the parent company
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Basic earnings per share
15.38%-0.11
14.29%-0.12
5.66%-0.5
15.38%-0.11
0.00%-0.12
0.00%-0.13
6.67%-0.14
22.06%-0.53
23.53%-0.13
25.00%-0.12
Diluted earnings per share
15.38%-0.11
14.29%-0.12
5.66%-0.5
15.38%-0.11
0.00%-0.12
0.00%-0.13
6.67%-0.14
22.06%-0.53
23.53%-0.13
25.00%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue -15.01%583K12.12%731K39.56%2.59M20.40%543K66.36%712K33.98%686K39.61%652K8.09%1.86M3.44%451K-13.71%428K
Operating revenue -15.01%583K12.12%731K39.56%2.59M20.40%543K66.36%712K33.98%686K39.61%652K8.09%1.86M3.44%451K-13.71%428K
Cost of revenue -14.98%352K12.21%441K39.55%1.56M20.22%327K66.28%429K34.42%414K39.36%393K8.00%1.12M3.42%272K-13.71%258K
Gross profit -15.07%231K11.97%290K39.57%1.03M20.67%216K66.47%283K33.33%272K40.00%259K8.21%738K3.47%179K-13.71%170K
Operating expense -15.78%10.35M-6.86%11.8M0.12%45.87M-16.48%9.75M2.23%11.16M7.29%12.29M7.64%12.67M16.95%45.82M12.23%11.68M20.77%10.92M
Selling and administrative expenses 7.41%3.75M61.70%5.94M-5.02%13.46M-14.47%2.79M-8.99%3.5M-0.09%3.5M3.08%3.68M14.14%14.17M1.12%3.26M31.30%3.85M
-General and administrative expense 7.41%3.75M61.70%5.94M-5.02%13.46M-14.47%2.79M-8.99%3.5M-0.09%3.5M3.08%3.68M14.14%14.17M1.12%3.26M31.30%3.85M
Research and development costs -24.99%6.6M-34.89%5.85M2.41%32.41M-17.26%6.96M8.34%7.66M10.53%8.8M9.62%8.99M18.26%31.65M17.23%8.42M15.72%7.07M
Operating profit 15.79%-10.12M7.25%-11.51M0.53%-44.84M17.06%-9.54M-1.22%-10.88M-6.82%-12.02M-7.12%-12.41M-17.11%-45.08M-12.38%-11.5M-21.54%-10.75M
Net non-operating interest income expense 0.00%-45K0.00%-45K0.00%-180K0.00%-45K0.00%-45K0.00%-45K0.00%-45K92.64%-180K93.00%-45K92.81%-45K
Non-operating interest expense 0.00%45K0.00%45K0.00%180K0.00%45K0.00%45K0.00%45K0.00%45K-92.64%180K-93.00%45K-92.81%45K
Other net income (expense) 171.43%209K3,068.75%507K65,400.00%655K433.02%353K154.88%209K185.19%77K900.00%16K-99.78%1K-138.27%-106K230.16%82K
Gain on sale of security 171.43%209K3,068.75%507K65,400.00%655K433.02%353K154.88%209K185.19%77K900.00%16K-99.78%1K-138.27%-106K230.16%82K
Income before tax 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Income tax
Net income 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Net income continuous Operations 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Minority interest income
Net income attributable to the parent company 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Basic earnings per share 15.38%-0.1114.29%-0.125.66%-0.515.38%-0.110.00%-0.120.00%-0.136.67%-0.1422.06%-0.5323.53%-0.1325.00%-0.12
Diluted earnings per share 15.38%-0.1114.29%-0.125.66%-0.515.38%-0.110.00%-0.120.00%-0.136.67%-0.1422.06%-0.5323.53%-0.1325.00%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg